Maintaining clinical improvement with intranasal esketamine in treatment resistant depression

Neuroscience Applied 2026 Open access

Read full text
Authors: Javier Peral, A.I. De Santiago-Díaz, M.A. Madrazo-Maza, E. Sáez Fuentes
DOI: 10.1016/j.nsa.2025.106723
Cited by: 1

Fields of Study & Subjects

Treatment of Major Depression Neurotransmitter Receptor Influence on Behavior Anxiety Depression Psychometrics Treatment Cognitive Processes

Publication details

Journal / source
Neuroscience Applied
Publisher
Elsevier BV
Volume
5
Pages
106723–106723
Publication date
1 January 2026
Language
EN